Fundraising FoxImux
New York City, US · 1 known investors
Find your way into Imux
Each arrow is one introduction. Sign up to fill in the first one.
81 people can intro you to Jason
Ask John Crowley to introduce you to Jason Tardio
You →John · together at Sepracor →Jason
Sign up to find every way you can get introduced to Imux
- Your email: who you already know at Imux, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Imux team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Immunic is a clinical-stage biopharmaceutical company developing oral small molecule treatments for neurologic and autoimmune diseases with unmet medical needs.
Founders & leadership
DH
Dr. Hella KohlhofCo-Founder, Chief Scientific Officer
JT
Jason TardioPresident and Chief Operating OfficerJason Tardio has held C-level pharmaceutical executive roles across specialty, rare disease, and large-market brands, with experience in general management, product launches, and cross-functional leadership in the United States, Latin America, and global markets.
Investors · 1
Frequently asked questions
- What does Imux do?
- Immunic is a clinical-stage biopharmaceutical company developing oral small molecule treatments for neurologic and autoimmune diseases with unmet medical needs.
- Who founded Imux?
- Imux was founded by Dr. Hella Kohlhof.
- Who are Imux's investors?
- Imux's investors include Fund+.
- Where is Imux headquartered?
- Imux is headquartered in New York City, US.